$MLYS 8-K SEC Filings

Filed On	Filing
19 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 16, 2026, the Board of Directors (the Board) of Mineralys Therapeutics, Inc. (the Company) appointed Kristine Peterson and Lonnel Coats to the Board effective as of October 19, 2026, increasing the size of the Board from seven...
11 Aug 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
03 Jun 2026	8-K: Other Events
03 Jun 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
22 May 2026	8-K: Submission of Matters to a Vote of Security Holders
06 May 2026	8-K: Results of Operations and Financial Condition
12 Mar 2026	8-K: Results of Operations and Financial Condition
09 Mar 2026	8-K: Regulation FD Disclosure; Other Events
06 Jan 2026	8-K: Regulation FD Disclosure; Other Events
10 Nov 2025	8-K: Results of Operations and Financial Condition
03 Sep 2025	8-K: Other Events
02 Sep 2025	8-K: Other Events
12 Aug 2025	8-K: Results of Operations and Financial Condition
17 Jun 2025	8-K: Regulation FD Disclosure; Other Events
22 May 2025	8-K: Submission of Matters to a Vote of Security Holders
12 May 2025	8-K: Results of Operations and Financial Condition
31 Mar 2025	8-K: Regulation FD Disclosure; Other Events
12 Mar 2025	8-K: Other Events
10 Mar 2025	8-K: Regulation FD Disclosure; Other Events
12 Feb 2025	8-K: Results of Operations and Financial Condition

Comments